Literature DB >> 28381193

Gene promoter methylation and protein expression of BRMS1 in uterine cervix in relation to high-risk human papilloma virus infection and cancer.

Maria Panagopoulou1, Maria Lambropoulou2, Ioanna Balgkouranidou1,3, Evangelia Nena4, Makrina Karaglani1, Christina Nicolaidou2, Anthi Asimaki5, Theocharis Konstantinidis4, Theodoros C Constantinidis4, George Kolios1, Stylianos Kakolyris3, Theodoros Agorastos5, Ekaterini Chatzaki1.   

Abstract

Cervical cancer is strongly related to certain high-risk types of human papilloma virus infection. Breast cancer metastasis suppressor 1 (BRMS1) is a tumor suppressor gene, its expression being regulated by DNA promoter methylation in several types of cancers. This study aims to evaluate the methylation status of BRMS1 promoter in relation to high-risk types of human papilloma virus infection and the development of pre-cancerous lesions and describe the pattern of BRMS1 protein expression in normal, high-risk types of human papilloma virus-infected pre-cancerous and malignant cervical epithelium. We compared the methylation status of BRMS1 in cervical smears of 64 women with no infection by high-risk types of human papilloma virus to 70 women with proven high-risk types of human papilloma virus infection, using real-time methylation-specific polymerase chain reaction. The expression of BRMS1 protein was described by immunohistochemistry in biopsies from cervical cancer, pre-cancerous lesions, and normal cervices. Methylation of BRMS1 promoter was detected in 37.5% of women with no high-risk types of human papilloma virus infection and was less frequent in smears with high-risk types of human papilloma virus (11.4%) and in women with pathological histology (cervical intraepithelial neoplasia) (11.9%). Methylation was detected also in HeLa cervical cancer cells. Immunohistochemistry revealed nuclear BRMS1 protein staining in normal high-risk types of human papilloma virus-free cervix, in cervical intraepithelial neoplasias, and in malignant tissues, where staining was occasionally also cytoplasmic. In cancer, expression was stronger in the more differentiated cancer blasts. In conclusion, BRMS1 promoter methylation and aberrant protein expression seem to be related to high-risk types of human papilloma virus-induced carcinogenesis in uterine cervix and is worthy of further investigation.

Entities:  

Keywords:  BRMS1; Methylation; cancer; epigenetic; human papilloma virus; uterine cervix

Mesh:

Substances:

Year:  2017        PMID: 28381193     DOI: 10.1177/1010428317697557

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  6 in total

Review 1.  BRMS1: a multifunctional signaling molecule in metastasis.

Authors:  Rosalyn C Zimmermann; Danny R Welch
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

2.  Epigenetics mechanisms mediate the miR-125a/BRMS1 axis to regulate invasion and metastasis in gastric cancer.

Authors:  Jianbo Xiong; Yi Tu; Zongfeng Feng; Daojiang Li; Zhouwen Yang; Qiuxia Huang; Zhengrong Li; Yi Cao; Zhigang Jie
Journal:  Onco Targets Ther       Date:  2019-09-12       Impact factor: 4.147

Review 3.  Circulating Cell-Free DNA in Breast Cancer: Searching for Hidden Information towards Precision Medicine.

Authors:  Maria Panagopoulou; Manel Esteller; Ekaterini Chatzaki
Journal:  Cancers (Basel)       Date:  2021-02-10       Impact factor: 6.639

4.  ENPP2 Methylation in Health and Cancer.

Authors:  Maria Panagopoulou; Dionysios Fanidis; Vassilis Aidinis; Ekaterini Chatzaki
Journal:  Int J Mol Sci       Date:  2021-11-04       Impact factor: 5.923

5.  ENPP2 Promoter Methylation Correlates with Decreased Gene Expression in Breast Cancer: Implementation as a Liquid Biopsy Biomarker.

Authors:  Maria Panagopoulou; Andrianna Drosouni; Dionysiοs Fanidis; Makrina Karaglani; Ioanna Balgkouranidou; Nikolaos Xenidis; Vassilis Aidinis; Ekaterini Chatzaki
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

6.  An epigenomic landscape of cervical intraepithelial neoplasia and cervical cancer using single-base resolution methylome and hydroxymethylome.

Authors:  Yingxin Han; Liyan Ji; Yanfang Guan; Mengya Ma; Pansong Li; Yinge Xue; Yinxin Zhang; Wanqiu Huang; Yuhua Gong; Li Jiang; Xipeng Wang; Hong Xie; Boping Zhou; Jiayin Wang; Junwen Wang; Jinghua Han; Yuliang Deng; Xin Yi; Fei Gao; Jian Huang
Journal:  Clin Transl Med       Date:  2021-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.